Anyone who regularly experiences migraines knows how frustrating their unpredictability can be. One morning, everything feels normal. A few hours later, a severe headache, nausea or sensitivity to light can make even simple activities difficult.
For millions of people, the uncertainty is almost as frustrating as the migraine itself. Planning work, social activities or family events becomes difficult when another attack could arrive without much warning.
Now, researchers have developed an artificial intelligence system that may help people prepare for their next migraine before it begins.
According to a study published in Neurology Open Access, the technology achieved 91.2 percent precision when predicting whether users would report a migraine the following day.
Also read: A blood test promises to detect over 50 cancers early but a major trial has revealed a problem
The study involved more than 53,000 people and examined hundreds of thousands of daily headache records.
But perhaps the most surprising discovery was what the AI actually relied on to make its predictions. Rather than focusing primarily on the warning symptoms traditionally associated with migraines, the system found its strongest clues in people's headache patterns over the previous month.
More than 53,000 people helped train the AI
The technology was developed by Theranica, the company behind Nerivio, a prescription medical device used to treat and help prevent migraines.
Unlike a conventional smartwatch, Nerivio is worn on the upper arm and delivers controlled electrical pulses that stimulate the body's natural pain-regulating pathways. Treatment sessions last 45 minutes, and the device is operated through a smartphone app.
Also read: 7 warning signs your sensitive skin could actually be rosacea
The device is cleared by the US Food and Drug Administration for migraine treatment and prevention in patients aged eight and older.
However, the new development involves something different: a prediction feature inside the app called Your Day Ahead.
Instead of waiting until a migraine begins, the feature analyzes information about a person's previous headaches and estimates how likely they are to experience another attack within the next 24 hours.
To evaluate this approach, researchers examined data collected from 53,065 Nerivio app users between January 2020 and July 2025.
Also read: Women who exercise more report fewer menopause symptoms and one benefit stands out
The analysis covered approximately 770,000 eligible daily records and included information from migraine diaries, questionnaires, demographic details and local weather conditions.
Seven different machine-learning algorithms were evaluated to determine which could best identify the patterns associated with next-day migraines.
The strongest-performing model produced results that attracted considerable attention.
The AI reached 91.2% precision, but what does that mean?
The researchers found that the best-performing AI model achieved 91.2 percent precision.
Also read: Scientists can now switch brain cells on and off with light and the discovery just won a Nobel Prize
In simple terms, when the system identified a day as one on which a migraine was likely to occur, that prediction matched a reported migraine approximately nine times out of ten in the study's evaluated data.
However, that does not mean the AI correctly predicted every migraine or performed with 91.2 percent accuracy overall.
Its total accuracy was 81 percent, while its sensitivity was 80 percent. Sensitivity measures how many actual migraine days the system successfully identified.
That means the model still failed to identify around one in five reported migraine days.
Also read: Scientists test AI-powered headset that could change how women manage menopause symptoms
There is also another important detail. Approximately 69 percent of the eligible days in the study dataset were reported as migraine days, meaning attacks were already relatively common among the records being analyzed.
The study also counted some days involving mild headache pain, not just severe migraine attacks.
These factors matter when interpreting the results. Although the findings are promising, they do not establish that the system will achieve the same performance among everyone who experiences migraines.
The biggest warning sign was not what doctors expected
For decades, doctors have encouraged patients to recognize symptoms that sometimes appear before a migraine begins.
These early warning signs, known as prodromal symptoms, can include unusual tiredness, neck stiffness, mood changes, food cravings and sensitivity to light or sound.
Some people experience these symptoms hours or even days before the headache phase of a migraine starts.
But the new research revealed that these familiar warning signs were not the strongest predictors of what would happen the next day.
According to Theranica's announcement of the findings, prodromal symptoms accounted for just 11.1 percent of the model's predictive contribution.
Instead, the most valuable information came from each person's headache history.
Features drawn from the previous 30 days accounted for approximately 56.3 percent of the model's predictive contribution. The single strongest feature was the average severity of headaches recorded during that period.
In other words, tracking how frequently and severely someone has experienced headaches over the past month appeared more useful to the AI than relying on traditional warning symptoms alone.
Dr. Chia-Chun Chiang, an associate professor of neurology and headache specialist at Mayo Clinic, said the findings could change how researchers approach migraine prediction.
He explained that a person's headache records may reveal important patterns that are difficult to recognize simply by looking for symptoms immediately before an attack.
The discovery suggests that consistently recording headaches could provide more useful information than many patients realize.
Another study found that smartwatches might also predict migraines
The Nerivio research is not the only recent study investigating whether technology could help predict migraine attacks.
A separate study published in Cephalalgia in September 2026 examined whether a wrist-worn biosensor could detect physical changes before a migraine began.
Researchers analyzed data from 27 adults who wore a device that continuously monitored several bodily signals, including heart rate, skin temperature, sweat-related electrical activity and movement.
The participants wore the sensors for approximately one month, allowing researchers to compare their physical measurements with the timing of migraine attacks.
Instead of relying primarily on information entered into an app, this approach attempted to identify changes in the body's automatic nervous system.
The results were encouraging.
Personalized AI models achieved an average accuracy of 82 percent when distinguishing periods shortly before a migraine from periods without an approaching attack. Their average precision was 75 percent, with prediction windows ranging from two to 12 hours before an attack.
However, researchers discovered an important limitation.
When they trained a general model using information from other participants and applied it to someone new, the system performed better than chance in only approximately one-third of participants.
That suggests migraine prediction may depend heavily on understanding each individual's personal patterns.
A system trained on one person's physiological signals may not work nearly as well for someone else.
Why predicting a migraine could make a difference
Migraine is much more than an ordinary headache. It is a neurological condition that can cause severe pain, nausea, vomiting and sensitivity to light, sound or movement.
Some people also experience visual disturbances known as aura, which can involve flashing lights, blind spots or unusual sensations before or during an attack.
For those affected, being able to anticipate an attack could make everyday life considerably easier.
A warning about an increased risk of migraine the following day might allow someone to rearrange demanding activities, prioritize sleep or avoid personal triggers they have already identified.
It could also encourage people to remain consistent with preventive treatment prescribed by their healthcare professional.
The American Migraine Foundation explains that preventive migraine treatment aims to reduce how often attacks occur, how severe they become and how long they last.
The organization also emphasizes the importance of having an appropriate treatment plan for when symptoms begin.
However, an AI prediction should not be used as a reason to take additional medication or change prescribed treatment without medical advice.
Theranica says its prediction feature is intended to help patients prepare and understand their migraine patterns, not diagnose the condition or recommend medication changes.
There is an important limitation behind the impressive numbers
Although the study involved an unusually large number of people, the researchers did not conduct a clinical trial to determine whether receiving AI-generated warnings actually improved patients' lives.
Instead, they analyzed existing information recorded by people already using the Nerivio app.
This creates several limitations.
First, people who use a prescription migraine device may experience more frequent or troublesome headaches than the average person with migraine.
They may also be more motivated to record their symptoms, meaning their data could differ from those of people who rarely track their headaches.
Second, the results depended on information reported by users rather than independent medical confirmation of every attack.
Finally, the research did not establish whether receiving a warning helped patients avoid attacks, reduce pain, miss fewer days of work or experience less anxiety.
As explained by NeurologyLive in its examination of the study, researchers still need to test the model in independent patient populations and determine whether its predictions lead to meaningful improvements in migraine care.
The study was also closely connected to the company developing the technology. Several authors were Theranica employees, and the company paid the article's publication fee, although the researchers reported no targeted study funding.
This does not invalidate the results, but independent research will be important before the technology's effectiveness can be established more broadly.
The prediction feature is already available
Unlike many experimental AI healthcare technologies, Your Day Ahead is already included in the Nerivio smartphone app.
According to the official Nerivio website, the feature uses each patient's recorded migraine patterns to estimate the likelihood of an attack during the following 24 hours.
The underlying wearable remains a prescription medical device in the United States, and the FDA clearance applies to its migraine treatment and prevention functions. The prediction feature should not be confused with a separately proven or approved method for preventing attacks.
Theranica says the device has been used in more than two million treatment sessions and that insurance plans covering approximately 158 million Americans now have policies that include Nerivio. Individual eligibility and reimbursement still depend on the patient's insurance plan.
The company hopes the AI feature will allow people to take a more active role in understanding and managing their condition.
But while the ability to forecast a migraine a day in advance could be valuable, the next challenge is proving that these predictions actually help.
For now, the findings provide an encouraging insight into migraine research: the most useful warning about tomorrow's headache may not be a sudden symptom today, but the pattern of headaches someone has been experiencing for weeks.
And as researchers continue improving personalized prediction systems, keeping a consistent headache diary may become an increasingly useful part of migraine management.
This article is made and published by Aksel Kryhlmand, who may have used AI in the preparation.